Biofilm formation by Clostridium difficile

Gut Microbes

Volumn 4, Issue 5, 2013, Pages

  Dapa, Tanja ^a   Unnikrishnan, Meera ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Anaerobic pathogen; Antibiotic resistance; Biofilm formation; Clostridium difficile; Sporulation

Indexed keywords

ADHESIN; CELL MEMBRANE PROTEIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; CYSTEINE PROTEINASE; DEOXYRIBONUCLEASE; FIBRONECTIN BINDING PROTEIN; GLUCOSE; METRONIDAZOLE; PROTEINASE K; RIFAMPICIN; S RIBOSYLHOMOCYSTEINASE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL FLAGELLUM; BACTERIAL GENE; BACTERIAL SURVIVAL; BACTERIUM CULTURE; BIOFILM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONFOCAL MICROSCOPY; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; NONHUMAN; RECURRENT INFECTION; REGULATOR GENE; REGULON; SPOROGENESIS;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE;

EID: 84883420795     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gutm.25862     Document Type: Article

References (52)

1. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009; 7:526-36; PMID:19528959; http://dx.doi.org/10.1038/ nrmicro2164
2. Lawley TD, Clare S, Walker AW, Goulding D, Stabler RA, Croucher N, et al. Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun 2009; 77:3661-9; PMID:19564382; http:// dx.doi.org/10.1128/IAI.00558-09
3. Deakin LJ, Clare S, Fagan RP, Dawson LF, Pickard DJ, West MR, et al. The Clostridium difficile spo0A gene is a persistence and transmission factor. Infect Immun 2012; 80:2704-11; PMID:22615253; http:// dx.doi.org/10.1128/IAI.00147-12
4. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010; 467:711-3; PMID:20844489; http://dx.doi. org/10.1038/nature09397
5. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, Phumoonna T, et al. Toxin B is essential for virulence of Clostridium difficile. Nature 2009; 458:1176-9; PMID:19252482; http://dx.doi. org/10.1038/nature07822
6. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005; 18:247-63; PMID:15831824; http://dx.doi.org/10.1128/CMR.18.2.247-263.2005
7. Barketi-Klai A, Hoys S, Lambert-Bordes S, Collignon A, Kansau I. Role of fibronectin-binding protein A in Clostridium difficile intestinal colonization. J Med Microbiol 2011; 60:1155-61; PMID:21349990; http://dx.doi.org/10.1099/jmm.0.029553-0
8. Calabi E, Calabi F, Phillips AD, Fairweather NF. Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues. Infect Immun 2002; 70:5770-8; PMID:12228307; http://dx.doi. org/10.1128/IAI.70.10.5770-5778.2002
9. Karjalainen T, Waligora-Dupriet AJ, Cerquetti M, Spigaglia P, Maggioni A, Mauri P, et al. Molecular and genomic analysis of genes encoding surfaceanchored proteins from Clostridium difficile. Infect Immun 2001; 69:3442-6; PMID:11292772; http:// dx.doi.org/10.1128/IAI.69.5.3442-3446.2001
10. Waligora AJ, Hennequin C, Mullany P, Bourlioux P, Collignon A, Karjalainen T. Characterization of a cell surface protein of Clostridium difficile with adhesive properties. Infect Immun 2001; 69:2144-53; PMID:11254569; http://dx.doi.org/10.1128/ IAI.69.4.2144-2153.2001
11. Janoir C, Péchiné S, Grosdidier C, Collignon A. Cwp84, a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins. J Bacteriol 2007; 189:7174-80; PMID:17693508; http://dx.doi. org/10.1128/JB.00578-07
12. Römling U, Balsalobre C. Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med 2012; 272:541-61; PMID:23025745; http://dx.doi.org/10.1111/ joim.12004
13. Davey ME, O'toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 2000; 64:847-67; PMID:11104821; http:// dx.doi.org/10.1128/MMBR.64.4.847-867.2000
14. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318-22; PMID:10334980; http://dx.doi.org/10.1126/science.284.5418.1318
15. Claret L, Miquel S, Vieille N, Ryjenkov DA, Gomelsky M, Darfeuille-Michaud A. The flagellar sigma factor FliA regulates adhesion and invasion of Crohn disease-associated Escherichia coli via a cyclic dimeric GMP-dependent pathway. J Biol Chem 2007; 282:33275-83; PMID:17827157; http:// dx.doi.org/10.1074/jbc.M702800200
16. Hannan TJ, Totsika M, Mansfield KJ, Moore KH, Schembri MA, Hultgren SJ. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev 2012; 36:616-48; PMID:22404313; http://dx.doi.org/10.1111/j.1574-6976.2012.00339.x
17. Kumagai Y, Matsuo J, Cheng Z, Hayakawa Y, Rikihisa Y. Cyclic dimeric GMP signaling regulates intracellular aggregation, sessility, and growth of Ehrlichia chaffeensis. Infect Immun 2011; 79:3905-12; PMID:21788390; http://dx.doi.org/10.1128/ IAI.05320-11
18. Lynch AS, Robertson GT. Bacterial and fungal biofilm infections. Annu Rev Med 2008; 59:415-28; PMID:17937586; http://dx.doi.org/10.1146/ annurev.med.59.110106.132000
19. Apa T, Leuzzi R, Ng YK, Baban ST, Adamo R, Kuehne SA, et al. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol 2013; 195:545-55; PMID:23175653; http://dx.doi.org/10.1128/JB.01980-12
20. Beloin C, Roux A, Ghigo JM. Escherichia coli biofilms. Curr Top Microbiol Immunol 2008; 322:249-89; PMID:18453280; http://dx.doi.org/10.1007/978-3-540-75418-3_12
21. Watnick PI, Lauriano CM, Klose KE, Croal L, Kolter R. The absence of a flagellum leads to altered colony morphology, biofilm development and virulence in Vibrio cholerae O139. Mol Microbiol 2001; 39:223-35; PMID:11136445; http://dx.doi. org/10.1046/j.1365-2958.2001.02195.x
22. Adamo R, Romano MR, Berti F, Leuzzi R, Tontini M, Danieli E, et al. Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharide. ACS Chem Biol 2012; 7:1420-8; PMID:22620974; http://dx.doi. org/10.1021/cb300221f
23. Calabi E, Ward S, Wren B, Paxton T, Panico M, Morris H, et al. Molecular characterization of the surface layer proteins from Clostridium difficile. Mol Microbiol 2001; 40:1187-99; PMID:11401722; http://dx.doi.org/10.1046/j.1365-2958.2001.02461.x
24. Kirby JM, Ahern H, Roberts AK, Kumar V, Freeman Z, Acharya KR, et al. Cwp84, a surface-associated cysteine protease, plays a role in the maturation of the surface layer of Clostridium difficile. J Biol Chem 2009; 284:34666-73; PMID:19808679; http:// dx.doi.org/10.1074/jbc.M109.051177
25. Kobayashi K. Gradual activation of the response regulator DegU controls serial expression of genes for flagellum formation and biofilm formation in Bacillus subtilis. Mol Microbiol 2007; 66:395-409; PMID:17850253; http://dx.doi.org/10.1111/j.1365-2958.2007.05923.x
26. Lemon KP, Freitag NE, Kolter R. The virulence regulator PrfA promotes biofilm formation by Listeria monocytogenes. J Bacteriol 2010; 192:3969-76; PMID:20511507; http://dx.doi.org/10.1128/ JB.00179-10
27. Barken KB, Pamp SJ, Yang L, Gjermansen M, Bertrand JJ, Klausen M, et al. Roles of type IV pili, flagellum-mediated motility and extracellular DNA in the formation of mature multicellular structures in Pseudomonas aeruginosa biofilms. Environ Microbiol 2008; 10:2331-43; PMID:18485000; http://dx.doi. org/10.1111/j.1462-2920.2008.01658.x
28. Hardie KR, Heurlier K. Establishing bacterial communities by 'word of mouth': LuxS and autoinducer 2 in biofilm development. Nat Rev Microbiol 2008; 6:635-43; PMID:18536728; http://dx.doi. org/10.1038/nrmicro1916
29. Vendeville A, Winzer K, Heurlier K, Tang CM, Hardie KR. Making 'sense' of metabolism: autoinducer-2, LuxS and pathogenic bacteria. Nat Rev Microbiol 2005; 3:383-96; PMID:15864263; http:// dx.doi.org/10.1038/nrmicro1146
30. Hammer BK, Bassler BL. Quorum sensing controls biofilm formation in Vibrio cholerae. Mol Microbiol 2003; 50:101-4; PMID:14507367; http://dx.doi. org/10.1046/j.1365-2958.2003.03688.x
31. Carter GP, Purdy D, Williams P, Minton NP. Quorum sensing in Clostridium difficile: analysis of a luxS-type signalling system. J Med Microbiol 2005; 54:119-27; PMID:15673504; http://dx.doi. org/10.1099/jmm.0.45817-0
32. López D, Kolter R. Extracellular signals that define distinct and coexisting cell fates in Bacillus subtilis. FEMS Microbiol Rev 2010; 34:134-49; PMID:20030732; http://dx.doi.org/10.1111/j.1574-6976.2009.00199.x
33. Underwood S, Guan S, Vijayasubhash V, Baines SD, Graham L, Lewis RJ, et al. Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. J Bacteriol 2009; 191:7296-305; PMID:19783633; http://dx.doi. org/10.1128/JB.00882-09
34. Molle V, Fujita M, Jensen ST, Eichenberger P, González-Pastor JE, Liu JS, et al. The Spo0A regulon of Bacillus subtilis. Mol Microbiol 2003; 50:1683-701; PMID:14651647; http://dx.doi.org/10.1046/ j.1365-2958.2003.03818.x
35. Vlamakis H, Chai Y, Beauregard P, Losick R, Kolter R. Sticking together: building a biofilm the Bacillus subtilis way. Nat Rev Microbiol 2013; 11:157-68; PMID:23353768; http://dx.doi.org/10.1038/nrmicro2960
36. Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW. Characterisation of Clostridium difficile biofilm formation, a role for Spo0A. PLoS One 2012; 7:e50527; PMID:23236376; http://dx.doi. org/10.1371/journal.pone.0050527
37. Deakin LJ, Clare S, Fagan RP, Dawson LF, Pickard DJ, West MR, et al. The Clostridium difficile spo0A gene is a persistence and transmission factor. Infect Immun 2012; 80:2704-11; PMID:22615253; http:// dx.doi.org/10.1128/IAI.00147-12
38. Piggot PJ. Spore development in Bacillus subtilis. Curr Opin Genet Dev 1996; 6:531-7; PMID:8939730; http://dx.doi.org/10.1016/S0959-437X(96)80080-3
39. Olson KM, Starks CM, Williams RB, O'Neil-Johnson M, Huang Z, Ellis M, et al. Novel pentadecenyl tetrazole enhances susceptibility of methicillin-resistant Staphylococcus aureus biofilms to gentamicin. Antimicrob Agents Chemother 2011; 55:3691-5; PMID:21646481; http://dx.doi. org/10.1128/AAC.00302-11
40. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9:34-9; PMID:11166241; http://dx.doi. org/10.1016/S0966-842X(00)01913-2
41. Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect 2012; 18(Suppl 6):21-7; PMID:23121551; http://dx.doi.org/10.1111/1469-0691.12046
42. Carman RJ, Boone JH, Grover H, Wickham KN, Chen L. In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy. Antimicrob Agents Chemother 2012; 56:6019-20; PMID:22908175; http://dx.doi.org/10.1128/ AAC.00974-12
43. Surawicz CM, Alexander J. Treatment of refractory and recurrent Clostridium difficile infection. Nat Rev Gastroenterol Hepatol 2011; 8:330-9; PMID:21502971; http://dx.doi.org/10.1038/nrgastro. 2011.59
44. Boehm A, Steiner S, Zaehringer F, Casanova A, Hamburger F, Ritz D, et al. Second messenger signalling governs Escherichia coli biofilm induction upon ribosomal stress. Mol Microbiol 2009; 72:1500-16; PMID:19460094; http://dx.doi.org/10.1111/j.1365-2958.2009.06739.x
45. Hoffman LR, D'Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005; 436:1171-5; PMID:16121184; http://dx.doi. org/10.1038/nature03912
46. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K. Persisters: a distinct physiological state of E. coli. BMC Microbiol 2006; 6:53; PMID:16768798; http://dx.doi.org/10.1186/1471-2180-6-53
47. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 2004; 230:13-8; PMID:14734160; http://dx.doi.org/10.1016/S0378-1097(03)00856-5
48. Tyerman JG, Ponciano JM, Joyce P, Forney LJ, Harmon LJ. The evolution of antibiotic susceptibility and resistance during the formation of Escherichia coli biofilms in the absence of antibiotics. BMC Evol Biol 2013; 13:22; PMID:23356665; http://dx.doi. org/10.1186/1471-2148-13-22
49. Lewis K. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 2008; 322:107-31; PMID:18453274; http://dx.doi. org/10.1007/978-3-540-75418-3_6
50. Probert HM, Gibson GR. Bacterial biofilms in the human gastrointestinal tract. Curr Issues Intest Microbiol 2002; 3:23-7; PMID:12400635
51. Croucher SC, Houston AP, Bayliss CE, Turner RJ. Bacterial populations associated with different regions of the human colon wall. Appl Environ Microbiol 1983; 45:1025-33; PMID:6847178
52. Donelli G, Vuotto C, Cardines R, Mastrantonio P. Biofilm-growing intestinal anaerobic bacteria. FEMS Immunol Med Microbiol 2012; 65:318-25; PMID:22444687; http://dx.doi.org/10.1111/j.1574-695X.2012.00962.x